Supply Chain
Supply chain management is a critical aspect of ensuring patients have lifesaving, life-enhancing medical technology when they need it. Supply chain disruptions or threats occur regularly, from natural disasters to raw material shortfalls. To help our members navigate these uncertainties, AdvaMed is forging partnerships to build greater resilience and ensure the delivery of health care is a priority. AdvaMed’s Supply Chain Working Group focuses on three key areas:
Horizon Scanning
AdvaMed supply chain experts meet twice monthly to assess potential threats and vulnerabilities to medtech supply chains. We evaluate a range of issues including geopolitical tensions, new regulations, weather events, supplier activity and raw material constraints to gauge potential impacts to medtech supply chains.
Public Private Partnerships
AdvaMed and its members are active in a number of public private partnerships with federal officials and key stakeholders in the health care delivery system. These partnerships facilitate tactical responses to acute supply chain challenges and provide platforms to exchange information in support of preparedness and response for the future.
Advocacy
AdvaMed works with federal partners to highlight major challenges to the medtech supply chain and identify policy solutions and strategies to support our industry to avoid disruptions in the health care delivery system that would impact patients. AdvaMed also advises government stakeholders on policies that support overall medtech supply chain resilience.
AdvaMed Submission to USTR on Supply Chain
With over 500 members and a robust industry spanning all 50 states, AdvaMed advocates for policies that reduce trade barriers, enhance workforce development, and promote global regulatory cooperation. This feedback emphasizes the importance of diversifying supply chains, fostering innovation, and ensuring a level playing field for U.S. manufacturers in global markets.
“If we fail to create reliable access to semiconductors, we will be less able to provide modern medicines to our most vulnerable populations.”
––Jim Farley, CEO, Ford Motor Co., and Pat Gelsinger, CEO, Intel
Wall Street Journal: “When the Chips are Down, Congress Should Support the Semiconductor Industry”